Ron Squarer
2018
In 2018, Ron Squarer earned a total compensation of $5.6M as Chief Executive Officer at Array BioPharma, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $473,582 |
|---|---|
| Option Awards | $3,331,808 |
| Salary | $615,760 |
| Stock Awards | $1,092,000 |
| Other | $51,716 |
| Total | $5,564,866 |
Squarer received $3.3M in option awards, accounting for 60% of the total pay in 2018.
Squarer also received $473.6K in non-equity incentive plan, $615.8K in salary, $1.1M in stock awards and $51.7K in other compensation.
Rankings
In 2018, Ron Squarer's compensation ranked 1,741st out of 14,244 executives tracked by ExecPay. In other words, Squarer earned more than 87.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,741 out of 14,244 | 88th |
Division Manufacturing | 618 out of 5,765 | 89th |
Major group Chemicals And Allied Products | 201 out of 2,128 | 91st |
Industry group Drugs | 158 out of 1,817 | 91st |
Industry Pharmaceutical Preparations | 118 out of 1,391 | 92nd |
Source: SEC filing on September 14, 2018.
Squarer's colleagues
We found four more compensation records of executives who worked with Ron Squarer at Array BioPharma in 2018.